Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin

SIMPLE SUMMARY: In a study analyzing 61 patients under the age of 39 diagnosed with malignant ovarian germ cell tumors (MOGCTs) between 2006 and 2022, the 5-year overall survival (OS) rate was 98.3%, and the event-free survival (EFS) rate was 84.9%. In total, 57 patients received bleomycin, etoposid...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Meerim, Suh, Jin Kyung, Lee, Jun Ah, Park, Hyeon Jin, Park, Eun Young, Yoo, Chong Woo, Lim, Myong Cheol, Park, Sang-Yoon, Park, Byung Kiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647703/
https://www.ncbi.nlm.nih.gov/pubmed/37958463
http://dx.doi.org/10.3390/cancers15215290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647703/
https://www.ncbi.nlm.nih.gov/pubmed/37958463
http://dx.doi.org/10.3390/cancers15215290

Ejemplares similares